Literature DB >> 3572815

H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine.

A Tsuji, T Terasaki, I Tamai, H Hirooka.   

Abstract

The characteristics of the transport of cefixime, a new p.o. cephalosporin, antibiotic, were studied by using brush-border membrane vesicles from the rat small intestine. The initial rate of uptake of cefixime was not affected by the presence of an inward gradient of either Na+ or other monovalent cations. With an intravesicular pHi of 7.5, optimal cefixime uptake occurred at an extravesicular pHo of 5.0, with about 6-fold acceleration compared with that in the absence of an inward proton gradient (pHi = pHo = 7.5). A protonophore, carbonyl-cyanide-4-trifluoromethoxy-phenylhydrazone, abolished the stimulating effect of low pHo. In the presence of a sufficient inward proton gradient (pHi = 7.5, pHo = 5.0), cefixime uptake showed an overshoot phenomenon and apparent saturation kinetics expressed by the Michaelis-Menten equation with the maximum rate of 2.67 +/- 0.06 nmol/30 sec/mg of protein and a Michaelis constant of 0.83 +/- 0.04 mM. Cefixime uptake was inhibited competitively by glycyl-L-proline and stimulated by the countertransport effect of this dipeptide. The other peptides also inhibited cefixime uptake significantly. A valinomycin-induced inside-negative K+-diffusion potential had a dramatic reducing effect on the uptake of dianionic cefixime. All the data obtained in this study demonstrate that cefixime transport across the brush-border membrane vesicles is carrier-mediated, independent of Na+ and dependent on a H+ gradient via the peptide transport systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572815

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  23 in total

Review 1.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

2.  [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].

Authors:  F Kees; K G Naber
Journal:  Infection       Date:  1990       Impact factor: 3.553

3.  Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2011-10-18       Impact factor: 2.611

4.  Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.

Authors:  Kunio Fujiwara; Masashi Shin; Tsubasa Miyazaki; Yasuhiro Maruta
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

5.  Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.

Authors:  C Padoin; M Tod; G Perret; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.

Authors:  M Hu; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

7.  Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles.

Authors:  J F Poschet; S M Hammond; P D Fairclough
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

8.  Peptide carrier-mediated transport in intestinal brush border membrane vesicles of rats and rabbits: cephradine uptake and inhibition.

Authors:  H Yuasa; G L Amidon; D Fleisher
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

9.  Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.

Authors:  O H Chan; H L Schmid; L A Stilgenbauer; W Howson; D C Horwell; B H Stewart
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 10.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.